Cargando…
Investigational Treatments for COVID-19 May Increase Ventricular Arrhythmia Risk through Drug Interactions
Autores principales: | Varshneya, Meera, Irurzun-Arana, Itziar, Campana, Chiara, Dariolli, Rafael, Gutierrez, Amy, Pullinger, Taylor K., Sobie, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Biophysical Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879810/ http://dx.doi.org/10.1016/j.bpj.2020.11.2085 |
Ejemplares similares
-
Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions
por: Varshneya, Meera, et al.
Publicado: (2020) -
Investigational Treatments for COVID‐19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions
por: Varshneya, Meera, et al.
Publicado: (2021) -
In vitro and In silico Models to Study SARS-CoV-2 Infection: Integrating Experimental and Computational Tools to Mimic “COVID-19 Cardiomyocyte”
por: Dariolli, Rafael, et al.
Publicado: (2021) -
Inflammation as a Risk Factor in Cardiotoxicity: An Important Consideration for Screening During Drug Development
por: Campana, Chiara, et al.
Publicado: (2021) -
Investigation of pathomechanisms of ventricular arrhythmias in cardiac laminopathies
por: Muchir, Antoine
Publicado: (2015)